Technology | December 15, 2014

Philips Launches Integrated Patient Management Solution for Lung Cancer Screening

System facilitates implementation of lung screening programs via patient management, radiology workflow and marketing tools

 Philips_DCAD-Lung-Report
 Philips_Lung cancer DualScreens
 Philips_Lung cancer Invivo_03_mpr_finding

December 15, 2014 — A new lung screening solution from Philips offers healthcare providers a faster and more definitive pathway to lung cancer detection and treatment. Making its debut at the 2014 Radiological Society of North America (RSNA) annual meeting in Chicago, the solution is comprised of products and services that enable healthcare providers to implement and manage a comprehensive computed tomography (CT) lung screening program which tracks and guides patients across the health continuum.

Philips' solution can be used with most low-dose CT scanners and consists of an integrated portfolio of products and services that together offers healthcare providers a complete program for early lung cancer detection and ability to easily assess individual patient status as well as overall program key performance indicators.

"Lung cancer has a significant mortality rate in the U.S., and given the large number of heavy smokers in the aging baby boomer population, we can expect to see that number rise in the coming years," said Andrea McKee, M.D., chair of the radiation oncology department at Lahey Hospital and Medical Center in Burlington, Mass. 

The Philips solution consists of several elements:

  • Services Marketing – Consultative services and marketing support enables health systems to reach high-risk patients and their primary care physicians (PCPs), provide connections to patient advocacy and support organizations, information sources and access to materials for marketing their lung cancer screening services.
  • Patient Management – "Control center" software tools allow providers to follow a set of customized clinical protocols and establish interfaces with other hospital systems (health information and radiology information systems [HIS/RIS], electronic medical records [EMR] and picture archive and communication systems [PACS]), providing clinical teams with a 360-degree view of patients. Customizable workflow tools also send timely and accurate notifications, and track participant history and touch points.
  • Radiology Workflow – CT lung image review and reporting offers specialized radiology software tools which facilitate review and reporting of serial CT lung exams to identify and easily follow areas of concern.
  • Physician Education Resources – Comprehensive online education portal to measure and report radiologist performance against a wide range of clinical cases, as well as structured education courses and other reference materials.

 

The Philips lung screening and management system will be available in North America in the first half of 2015.

For more information: www.philips.com/healthcare

Related Content

Infervision's newly FDA approved CT lung AI application sets a new standard
News | Artificial Intelligence | July 10, 2020
July 10, 2020 — Infervision announced U.S.
Artificial intelligence (AI)-assisted software was used to identify inflammatory tissues in lung and automatically segment inflammatory lesions. Three-dimensional image shows regions of COVID-19 pneumonia in lung through AI postprocessing. Image courtesy of the American Journal of Roentgenology (AJR)

Artificial intelligence (AI)-assisted software was used to identify inflammatory tissues in lung and automatically segment inflammatory lesions. Three-dimensional image shows regions of COVID-19 pneumonia in lung through AI postprocessing. Image courtesy of the American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | July 10, 2020
July 10, 2020 — An open-access Ameri
A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

News | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — With increased lung CT exam paradigms being used in the current...

Image courtesy of GE Healthcare

Feature | Mobile C-Arms | July 08, 2020 | By Melinda Taschetta-Millane
Moblie C-arms have seen several advances over the past de
Changes outlined in new draft U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations will greatly increase the number of Americans eligible for screening and help medical providers save thousands more lives each year.

Image courtesy of Cerner

News | Lung Imaging | July 08, 2020
July 8, 2020 — Changes outlined in new draft U.S.
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America

News | Coronavirus (COVID-19) | June 26, 2020
June 26, 2020 — In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association wit
Researchers from five infectious disease hospitals across four districts in Guangzhou, China found that the less pulmonary consolidation on chest CT, the greater the possibility of negative initial reverse transcription–polymerase chain reaction (RT-PCR) results for 21 patients (nine men, 12 women; age range, 26–90 years)

Comparison of CT features between groups with negative and positive initial RT-PCR results.
aThe difference was statistically significant in comparison of the two groups (p < 0.05).

News | Coronavirus (COVID-19) | June 18, 2020
June 18, 2020 —